HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China
· Delayed Price · Currency is CNY 3.620
+0.010 (0.28%)
Apr 29, 2026, 3:04 PM CST
SHE:002437 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 8,072 | 6,852 | 5,677 | 5,517 | 5,583 | 6,397 | Upgrade
|
| Market Cap Growth | 34.52% | 20.71% | 2.89% | -1.18% | -12.72% | -9.06% | Upgrade
|
| Enterprise Value | 7,164 | 6,115 | 5,277 | 5,430 | 5,794 | 6,481 | Upgrade
|
| Last Close Price | 3.62 | 3.07 | 2.49 | 2.51 | 2.54 | 2.91 | Upgrade
|
| PE Ratio | 19.59 | 18.18 | 24.39 | 45.85 | - | 142.01 | Upgrade
|
| Forward PE | - | 24.55 | 24.55 | 24.55 | 24.55 | 24.55 | Upgrade
|
| PS Ratio | 3.80 | 3.21 | 2.33 | 2.10 | 1.80 | 2.03 | Upgrade
|
| PB Ratio | 3.36 | 3.15 | 2.88 | 3.23 | 3.28 | 3.23 | Upgrade
|
| P/TBV Ratio | 4.33 | 4.24 | 4.01 | 5.01 | 5.36 | 5.36 | Upgrade
|
| P/FCF Ratio | 37.03 | - | 16.31 | 22.56 | 24.42 | 26.69 | Upgrade
|
| P/OCF Ratio | 33.69 | - | 13.81 | 20.12 | 21.34 | 23.33 | Upgrade
|
| EV/Sales Ratio | 3.37 | 2.86 | 2.16 | 2.07 | 1.86 | 2.06 | Upgrade
|
| EV/EBITDA Ratio | 23.01 | - | 16.04 | 19.71 | 26.87 | 25.45 | Upgrade
|
| EV/EBIT Ratio | 25.07 | 15.10 | 23.42 | 31.58 | 67.68 | 56.03 | Upgrade
|
| EV/FCF Ratio | 32.86 | - | 15.16 | 22.20 | 25.35 | 27.04 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.03 | 0.00 | 0.40 | 0.85 | 0.79 | Upgrade
|
| Debt / EBITDA Ratio | 0.07 | - | 0.01 | 2.45 | 6.75 | 5.99 | Upgrade
|
| Debt / FCF Ratio | 0.10 | - | 0.01 | 2.76 | 6.37 | 6.50 | Upgrade
|
| Net Debt / Equity Ratio | -0.38 | -0.35 | -0.26 | -0.02 | 0.10 | 0.03 | Upgrade
|
| Net Debt / EBITDA Ratio | - | - | -1.55 | -0.13 | 0.77 | 0.25 | Upgrade
|
| Net Debt / FCF Ratio | -4.25 | - | -1.46 | -0.15 | 0.73 | 0.26 | Upgrade
|
| Asset Turnover | 0.71 | - | 0.82 | 0.73 | 0.71 | 0.68 | Upgrade
|
| Inventory Turnover | 6.01 | - | 6.00 | 5.42 | 4.81 | 2.30 | Upgrade
|
| Quick Ratio | 1.57 | - | 0.80 | 0.67 | 0.67 | 0.68 | Upgrade
|
| Current Ratio | 1.90 | - | 1.07 | 0.82 | 0.78 | 0.82 | Upgrade
|
| Return on Equity (ROE) | 19.11% | 18.16% | 13.17% | 7.54% | -15.72% | 2.75% | Upgrade
|
| Return on Assets (ROA) | 5.93% | - | 4.71% | 2.97% | 1.22% | 1.57% | Upgrade
|
| Return on Invested Capital (ROIC) | 18.35% | 25.84% | 12.27% | 7.06% | 4.38% | 3.27% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.70% | - | 11.30% | 9.90% | 4.90% | 5.70% | Upgrade
|
| Earnings Yield | 5.10% | 5.50% | 4.10% | 2.18% | -5.22% | 0.70% | Upgrade
|
| FCF Yield | 2.70% | - | 6.13% | 4.43% | 4.09% | 3.75% | Upgrade
|
| Payout Ratio | 0.36% | - | 4.02% | 36.41% | - | 157.49% | Upgrade
|
| Buyback Yield / Dilution | 1.96% | 3.07% | -2.82% | -0.05% | -0.07% | 0.04% | Upgrade
|
| Total Shareholder Return | 1.96% | 3.07% | -2.82% | -0.05% | -0.07% | 0.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.